Journal of Antimicrobial Chemotherapy (1999) 43, 511-515
© 1999 The British Society for Antimicrobial Chemotherapy
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands
a Department of Clinical Microbiology and Infection Control, b Department of Gastroenterology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands
Successful treatment of Helicobacter pylori infection is becoming compromised by emerging resistance. We report the prevalence rates of H. pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. A total of 231 H. pylori clinical isolates were collected throughout the country over a period of 6 months during 1997-1998. The MICs of the above-mentioned antibiotics were determined in a single laboratory. The overall percentage of resistance for clarithromycin and metronidazole was 1.7% and 21.2%, respectively. None of the strains was resistant to amoxycillin or tetracycline. The primary resistance rate of trovafloxacin was as high as 4.7%. Since trovafloxacin has not yet been introduced on to the Dutch market, the resistance is probably induced by the use of other quinolones. Our data indicate that treatment outcome would benefit from susceptibility testing before starting therapy, especially when prescribing metronidazole.
* Correspondence address. Department of Clinical Microbiology and Infection Control, University Hospital Vrije Universiteit, PO Box 7057 MB, Amsterdam, The Netherlands. Tel +31-20-4440488; Fax +31-20-4440473; E-mail yj.debets{at}azvu.nl
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-C. Wang, W.-Y. Li, D.-C. Wu, J.-J. Wang, C.-H. Wu, J.-J. Liao, and C.-K. Lin In vitro activity of 2-methoxy-1,4-naphthoquinone and stigmasta-7,22-diene-3{beta}-ol from Impatiens balsamina L. against multiple antibiotic-resistant Helicobacter pylori Evid. Based Complement. Altern. Med., September 22, 2009; (2009) nep147v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alvarez, J. I. Moncayo, J. J. Santacruz, M. Santacoloma, L. F. Corredor, and E. Reinosa Antimicrobial Susceptibility and Mutations Involved in Clarithromycin Resistance in Helicobacter pylori Isolates from Patients in the Western Central Region of Colombia Antimicrob. Agents Chemother., September 1, 2009; 53(9): 4022 - 4024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Megraud Helicobacter pylori and antibiotic resistance Gut, November 1, 2007; 56(11): 1502 - 1502. [Full Text] [PDF]
|
|
|
|
 |
|
 K.-A. Moder, F. Layer, W. Konig, and B. Konig Rapid screening of clarithromycin resistance in Helicobacter pylori by pyrosequencing J. Med. Microbiol., October 1, 2007; 56(10): 1370 - 1376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Glocker, H.-P. Stueger, and M. Kist Quinolone Resistance in Helicobacter pylori Isolates in Germany Antimicrob. Agents Chemother., January 1, 2007; 51(1): 346 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kamoda, K. Anzai, J.-i. Mizoguchi, M. Shiojiri, T. Yanagi, T. Nishino, and S. Kamiya In Vitro Activity of a Novel Antimicrobial Agent, TG44, for Treatment of Helicobacter pylori Infection. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3062 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Posteraro, G. Branca, M. Sanguinetti, S. Ranno, G. Cammarota, S. Rahimi, M. De Carlo, B. Posteraro, and G. Fadda Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay J. Antimicrob. Chemother., January 1, 2006; 57(1): 71 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Lee, J.-H. Shin, I. H. Roe, S. G. Sohn, J. H. Lee, G. H. Kang, H.-K. Lee, B. C. Jeong, and S. H. Lee Impact of Clarithromycin Resistance on Eradication of Helicobacter pylori in Infected Adults Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1600 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M Gerrits, E.-J. van der Wouden, D. A Bax, A. A van Zwet, A. H. van Vliet, A. de Jong, J. G Kusters, J. C Thijs, and E. J Kuipers Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori J. Med. Microbiol., November 1, 2004; 53(11): 1123 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nahar, A. K. Mukhopadhyay, R. Khan, M. M. Ahmad, S. Datta, S. Chattopadhyay, S. C. Dhar, S. A. Sarker, L. Engstrand, D. E. Berg, et al. Antimicrobial Susceptibility of Helicobacter pylori Strains Isolated in Bangladesh J. Clin. Microbiol., October 1, 2004; 42(10): 4856 - 4858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Khan, S. Nahar, J. Sultana, M. M. Ahmad, and M. Rahman T2182C Mutation in 23S rRNA Is Associated with Clarithromycin Resistance in Helicobacter pylori Isolates Obtained in Bangladesh Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3567 - 3569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Megraud H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut, September 1, 2004; 53(9): 1374 - 1384. [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Lui, K.-G. Yeoh, and B. Ho Metronidazole-Resistant Helicobacter pylori Is More Prevalent in Patients with Nonulcer Dyspepsia than in Peptic Ulcer Patients in a Multiethnic Asian Population J. Clin. Microbiol., November 1, 2003; 41(11): 5011 - 5014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kuyvenhoven, F. A. M. van Balen, and T. J. M. Verheij Outpatient antibiotic prescriptions from 1992 to 2001 in The Netherlands J. Antimicrob. Chemother., October 1, 2003; 52(4): 675 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Kwon, M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2169 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fontana, M. Favaro, S. Minelli, A. A. Criscuolo, A. Pietroiusti, A. Galante, and C. Favalli New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pylori Clinical Isolates Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3765 - 3769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dailidiene, M. T. Bertoli, J. Miciuleviciene, A. K. Mukhopadhyay, G. Dailide, M. A. Pascasio, L. Kupcinskas, and D. E. Berg Emergence of Tetracycline Resistance in Helicobacter pylori: Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3940 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Gerrits, M. R. de Zoete, N. L. A. Arents, E. J. Kuipers, and J. G. Kusters 16S rRNA Mutation-Mediated Tetracycline Resistance in Helicobacter pylori Antimicrob. Agents Chemother., September 1, 2002; 46(9): 2996 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. WOLLE, A. LEODOLTER, P. MALFERTHEINER, and W. KONIG Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000 J. Med. Microbiol., August 1, 2002; 51(8): 705 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Chopra and M. Roberts Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 232 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Paul, S. Postius, K. Melchers, and K. P. Schäfer Mutations of the Helicobacter pylori Genes rdxA and pbp1 Cause Resistance against Metronidazole and Amoxicillin Antimicrob. Agents Chemother., March 1, 2001; 45(3): 962 - 965. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kato, Y. Yamaoka, J. J. Kim, R. Reddy, M. Asaka, K. Kashima, M. S. Osato, F. A. K. El-Zaatari, D. Y. Graham, and D. H. Kwon Regional Differences in Metronidazole Resistance and Increasing Clarithromycin Resistance among Helicobacter pylori Isolates from Japan Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2214 - 2216. [Abstract] [Full Text]
|
|